Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hiroshige Yoshioka

Pneumatosis Cystoides Intestinalis After Gefitinib Therapy for Pulmonary Adenocarcinoma

Journal of Thoracic Oncology

English

How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?

Journal of Thoracic Oncology

English

Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

Journal of Thoracic Oncology

English

Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib

English

Re-Biopsy Status Among Non-Small Cell Lung Cancer Patients in Japan: A Retrospective Study

English

Detection of Epidermal Growth Factor Receptor Gene T790M Mutation in Cytology Samples Using the Cobas ® EGFR Mutation Test

English

Neutrophil-To-Lymphocyte Ratio as an Early Marker of Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Nivolumab

International Journal of Clinical Oncology

English

Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-Induced Methemoglobinemia

Internal Medicine

Medicine

2015

English

Successful Treatment of Non-Small Cell Lung Cancer With Gefitinib After Severe Erlotinib-Related Hepatotoxicity

Internal Medicine

Medicine

2012

English

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia

Internal Medicine

Medicine

2011

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hiroshige Yoshioka

Pneumatosis Cystoides Intestinalis After Gefitinib Therapy for Pulmonary Adenocarcinoma

How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?

Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib

Re-Biopsy Status Among Non-Small Cell Lung Cancer Patients in Japan: A Retrospective Study

Detection of Epidermal Growth Factor Receptor Gene T790M Mutation in Cytology Samples Using the Cobas ® EGFR Mutation Test

Neutrophil-To-Lymphocyte Ratio as an Early Marker of Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Nivolumab

Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-Induced Methemoglobinemia

Successful Treatment of Non-Small Cell Lung Cancer With Gefitinib After Severe Erlotinib-Related Hepatotoxicity

Validation of Scoring Systems for Predicting Severe Community-Acquired Pneumonia